Market Herald logo

Find out more about this capital raise

Be the first with the news that moves the market
  • Singular Health Group (SHG) is gearing up for its float on the ASX, by launching an initial public offering (IPO) to raise between $5 million and $6 million
  • The medical technology company is offering up to 30 million shares under the IPO, each priced at 20 cents each
  • That will give the soon to be listed healthcare stock a market cap of around $20 million upon entering official quotation
  • The IPO is due to close on January 22, before the new shares under the public offer will be issued on January 27
  • Singular Health Group is expected to list on the ASX on February 4

Singular Health Group (SHG) is gearing up for its float on the ASX, by launching an initial public offering (IPO).

The IPO aims to raise between $5 million and $6 million for the medical technology company.

Under the public offer, up to 30 million shares will be offered to investors, at a price of 20 cents each.

That will give the soon to be listed healthcare stock a market cap of between $19.4 million and $20.4 million upon entering official quotation.

Commenting on the company’s future plans, Singular Health Group’s Non-Executive Chairman Denning Chong said the focus will be on developing software.

“Singular Health is a medical technology company focused on the development of medical software for the visualisation, manipulation and transfer of medical imaging data in 3D and virtual reality,” he said.

“Singular Health has acquired and developed the proprietary and patented Volumetric Rendering Platform which aids medical practitioners, patients, educators and students to view complex 2D medical images in 3D and virtual reality,” Denning added.

The company’s IPO is due to close on January 22, before the new shares under the public offer will be issued on January 27.

Singular Health Group is then expected to list on the ASX on February 4.

SHG by the numbers
More From The Market Herald

" Carnaby Resources (ASX:CNB) ends week in a trading halt

Carnaby Resources (ASX:CNB) enters a trading halt as it plans an upcoming capital raise.

" Askari Metals (ASX:AS2) plans to raise capital for lithium purchase

Askari Metals (AS2) has entered a trading halt as it plans an upcoming capital raise.
Telix Pharmaceuticals (ASX:TLX) - CEO, Christian Behrenbruch

" Telix Pharmaceuticals (ASX:TLX) planning capital raise

Telix Pharmaceuticals (ASX:TLX) enters a trading halt while it plans an upcoming capital raise.
Alice Queen (ASX:AQX) - Managing Director, Andrew Buxton

" Alice Queen (ASX:AQX) halts trade ahead of fresh capital

Mineral exploration company Alice Queen (ASX:AQX) has entered a trading halt ahead of a proposed capital…